Skip to content

CytoPeel CP3

by Emage Medical, LLC

CytoPeel CP3 is a multi-modality skin surface treatment system (FDA Class I; FDA product code GFE, Brush, Dermabrasion, Powered) made by Emage Medical, LLC, listed in FDA GUDID since 22 May 2025 (UDI-DI 00860012651009), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860012651009 UDI-DI Date22 May 2025ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Powered Dermabrasion Device
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
CytoPeel
Generic name
Multi-modality skin surface treatment system
Model / reference
CP3
Primary DI / UDI-DI
00860012651009
FDA product code
GFE
GMDN term
Multi-modality skin surface treatment system
Device class
Class I
Regulation number
878.4820
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Multi-modality skin surface treatment system.

Other devices from Emage Medical, LLC

See all devices from Emage Medical, LLC →

Properties

  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)